Experience in Being With Advanced Heart Failure Patients

October 12, 2016 updated by: National Taiwan University Hospital

National Taipei University of Nursing and Health Science

The purpose of this study is to explore the experience in being with advanced Heart failure patients.

Study Overview

Status

Unknown

Conditions

Detailed Description

The aim is to explore the experience of advanced Heart failure patients during the disease trajectory in Taiwan.

Study Type

Observational

Enrollment (Anticipated)

18

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zhongzheng
      • Taipei, Zhongzheng, Taiwan, 10002
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

the study population is diagnosis of advanced heart failure with NYHA class 3 to 4.

Description

Inclusion criteria:

  • the patients' conscious must be clear,
  • vital sign is stable,
  • and can communicate in Mandarin Chinese or Taiwanese.

exclusion criteria:

  • consciousness is unclear
  • and can't have effective communication to interviewer.
  • the patient reject to join this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
advanced heart failure
the patients was diagnostic on Chronic heart failure with NYHA class 3 and 4, AHA stage D, or LVEF<40%.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A qualitative research to decribe the experience with advanced Heart failure patients
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks.
describe patterns of diseases traits
participants will be followed for the duration of hospital stay, an expected average of 6 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: keidei kao, master, study

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Anticipated)

April 1, 2017

Study Completion (Anticipated)

April 1, 2017

Study Registration Dates

First Submitted

April 22, 2015

First Submitted That Met QC Criteria

May 4, 2015

First Posted (Estimate)

May 7, 2015

Study Record Updates

Last Update Posted (Estimate)

October 13, 2016

Last Update Submitted That Met QC Criteria

October 12, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 201503067RIND

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

because the data is still discussing with professional expert. and we think the data is not reach saturation yet.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

3
Subscribe